Funded Tech Companies
SpliSense
SpliSense, based in Jerusalem, received investment capital from Cystic Fibrosis Foundation and private investors.
Company Overview
Company Name
SpliSense
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Biohouse Labs, Minrav Bldg. 1st Floor, Haddasah Ein Karem
Jerusalem, 9112101
Israel
Jerusalem, 9112101
Israel
Phone
Website
Email Address
Company Background Information
Overview
SpliSense is a clinical stage company focused on transformative RNA-based treatments. Our pioneering platform harnesses Antisense Oligonucleotides (ASOs) for treatment of pulmonary diseases. Using an innovative approach, SpliSense aims to target the root cause of the disease, to overcome specific genetic mutations and modulate proteins expression and function.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/16/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gili Hart
Chief Scientific Officer
Batsheva Kerem
VP - Operations
Asaf Cohen
VP - R & D
Efrat Galai
VP - Regulatory Affairs
Lital Friedman
Company Investors
- Cystic Fibrosis Foundation
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs